Authors

Jacob Rolin

Files

Download

Download Full Text (13.5 MB)

Description

The utilization of T-cell immunotherapy stands as a promising strategy to addressing various ailments, most notably cancer, by leveraging endogenous T cells or genetically modified T cells. The augmentation of therapeutic T cells ex vivo remains a pivotal juncture within the manufacturing process that is inevitable for attainment of ample cell quantities. The enhancement of the enduring presence of the transplanted therapeutic T cells remains of paramount significance for favorable results. This research delves into the plausibility of amplifying human T cells while preventing undue differentiation through the employment of microbeads veneered with an innovative peptide ligand that targets CD3𝜀 (WSLGYTG). The isolation of human pan T cells from the PBMCs of healthy donors ensued via the EasySep Human Pan T Cell Isolation Kit. The proliferation ofT cell was induced by the use of microbeads conjugated with the peptide ligand, juxtaposed against a control group employing the current industry gold standard, DynabeadsⓇ Human T-Activator CD3/CD28. Evident in the experimental group was heightened cell amplification and a mitigated propensity for displaying CD45RO, a marker for more differentiated T cell phenotypes, compared to the control group. These encouraging preliminary findings insinuate the potential of microbeads embellished with the innovative peptide ligand in facilitating the expansion of therapeutic T cells tailored for immunotherapeutic pursuits. Further scrutiny is imperative to optimize and exploit this methodology in the realm of more efficacious T-cell immunotherapies.

Program

Research and Creative Experience for Undergraduates (RCEU)

Department

Chemical and Materials Engineering

College Name

College of Engineering

Advisor/Mentor

Kyung-Ho Roh

Publication Date

9-1-2023

Document Type

Poster

Keywords

Immunotherapy, microbeads, peptide ligand, T cell Phenotypes

Expansion of T Cells Using Microbeads Coated with Novel Peptide Ligand against CD3

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.